Genetic Engineering & Biotechnology News: Alzheimer’s and Other Tauopathies May Depend on RNA Surveillance

April 14, 2022
 

MD-PhD student Gabrielle Zuniga, Dr. Bess Frost, Dr. Nicolas Musi and Dr. Sudha Seshadri, of the Barshop and Biggs Institutes, are quoted in this article.     Read More


Fierce Biotech: Liver enzyme might hold the secret to new obesity treatments

April 14, 2022
 

Dr. Masahiro Morita of the Sam and Ann Barshop Institute and Department of Molecular Medicine; Dr. Sakie Katsumura, postdoctoral fellow in the Morita lab; and Dr. Nicolas Musi, director of the Barshop Institute and professor in the Department of Medicine, are quoted in this article.   Read More


San Antonio Report: BA.2 coronavirus subvariant detected in half of Bexar County cases

April 13, 2022
 

Dr. Marjorie David, Pathology and Laboratory Medicine, is quoted in this San Antonio Report article about the BA.2 variant in Bexar County and how UT Health San Antonio pathology lab is the only one in the county performing genome sequencing to determine variants of the coronavirus. Read story


Yahoo Finance: Boosting liver mRNAs curbs appetite, body weight in obese mice

April 6, 2022
 

Dr. Masahiro Morita, PhD, of the Sam and Ann Barshop Institute and Department of Molecular Medicine; Dr. Sakie Katsumura, DDS, PhD, postdoctoral fellow in the Morita lab; and Dr. Nicolas Musi, MD, director of the Barshop Institute and professor in the Department of Medicine, are quoted in this article. Read More


San Antonio Business Journal: California recruit to head UT Health San Antonio’s huge funding push

April 6, 2022
 

This article profiles Anamaria Repetti, who has been tapped as the institution’s new vice president for development and chief development officer to lead the university’s Office of Institutional Advancement and its fundraising efforts. Read More 


KSAT 12: Here are some newer COVID drugs experts think you should know more about

April 5, 2022
 

Dr. Barbara Taylor, Infectious Diseases, was interviewed for this story about newer COVID-19 drugs deemed successful in trials.   Read More